Cybin (HELP) Current Assets (2021 - 2026)
Cybin (HELP) posted quarterly Current Assets of $184.5 million for Q1 2026, up 59.53% year-on-year from $115.7 million in Q1 2025, and down 17.22% on a QoQ basis from $222.9 million in Q4 2025.
Cybin (HELP) Current Assets (2021 - 2026) Analysis & Trends
Cybin (HELP) has reported Current Assets for 6 consecutive years, with $184.5 million the latest figure, recorded in Q1 2026.
- Quarterly Current Assets rose 59.53% year-over-year to $184.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $184.5 million (up 59.53% YoY) and the FY2026 annual result came in at $184.5 million, up 59.83% from the prior year.
- Current Assets fell to $184.5 million in Q1 2026 per HELP's latest filing, from $222.9 million in the prior quarter.
- Over the last five years, Current Assets for HELP reached as high as $222.9 million in Q4 2025 and fell as low as $19.0 million in Q2 2023.
- A 5-year average of $100.0 million and a median of $115.7 million in 2025 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets sank 59.57% — and 2024, when it jumped 674.47%.
- Year by year, Current Assets stood at $22.2 million in 2022, then jumped by 61.35% to $35.8 million in 2023, then soared by 235.44% to $120.0 million in 2024, then jumped by 85.68% to $222.9 million in 2025, then fell by 17.22% to $184.5 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $184.5 million, $222.9 million, and $114.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | 184.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 184.52 Mn |
| Dec 31, 2025 | 222.90 Mn |
| Sep 30, 2025 | 114.58 Mn |
| Jun 30, 2025 | 143.65 Mn |
| Mar 31, 2025 | 115.67 Mn |
| Dec 31, 2024 | 120.04 Mn |
| Sep 30, 2024 | 131.02 Mn |
| Jun 30, 2024 | 146.79 Mn |
| Mar 31, 2024 | 162.18 Mn |
| Dec 31, 2023 | 35.79 Mn |
| Sep 30, 2023 | 19.95 Mn |
| Jun 30, 2023 | 18.95 Mn |
| Feb 28, 2023 | 31.90 Mn |
| Dec 31, 2022 | 22.18 Mn |
| Sep 30, 2022 | 29.36 Mn |
| Dec 31, 2021 | 54.85 Mn |
| Sep 30, 2021 | 63.12 Mn |
| Jun 30, 2021 | 46.83 Mn |
| Mar 31, 2021 | 52.53 Mn |